COVID-19 and Preparing Planetary Health for Future Ecological Crises: Hopes from Glycomics for Vaccine Innovation

OMICS. 2021 Apr;25(4):234-241. doi: 10.1089/omi.2021.0011. Epub 2021 Mar 31.

Abstract

A key lesson emerging from COVID-19 is that pandemic proofing planetary health against future ecological crises calls for systems science and preventive medicine innovations. With greater proximity of the human and animal natural habitats in the 21st century, it is also noteworthy that zoonotic infections such as COVID-19 that jump from animals to humans are increasingly plausible in the coming decades. In this context, glycomics technologies and the third alphabet of life, the sugar code, offer veritable prospects to move omics systems science from discovery to diverse applications of relevance to global public health and preventive medicine. In this expert review, we discuss the science of glycomics, its importance in vaccine development, and the recent progress toward discoveries on the sugar code that can help prevent future infectious outbreaks that are looming on the horizon in the 21st century. Glycomics offers veritable prospects to boost planetary health, not to mention the global scientific capacity for vaccine innovation against novel and existing infectious agents.

Keywords: COVID-19; ecology; glycomics; sugar code; systems science; third alphabet of life; vaccines.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • COVID-19 / epidemiology*
  • COVID-19 / immunology
  • COVID-19 / prevention & control
  • COVID-19 / transmission
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / biosynthesis
  • Ecosystem
  • Global Health / economics
  • Global Health / trends
  • Glycomics / organization & administration*
  • Humans
  • International Cooperation
  • Mass Vaccination / methods
  • Pandemics / prevention & control*
  • Preventive Medicine / methods
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / pathogenicity*
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / immunology
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / biosynthesis
  • Zoonoses / epidemiology*
  • Zoonoses / immunology
  • Zoonoses / prevention & control
  • Zoonoses / transmission
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Synthetic
  • spike protein, SARS-CoV-2